News

"Diabetes is a growing health concern worldwide and this milestone brings us one step closer to being able to offer patients and physicians in the European Union a

MCL is a rare and aggressive blood cancer that usually occurs in older adults. VELCADE, in combination with other agents, is currently licensed to treat patients with Multiple

TAS-102 achieved statistically significant improvements in overall survival (OS) and progression-free survival (PFS) in patients with refractory metastatic colorectal cancer (mCRC) whose disease had progressed after or who

The company said that the CHMP has recommended doctors to prescribe Avastin to treat ovarian cancer in cases where the disease proves resistant to chemotherapies containing platinum. Roche

In the long history of diabetes treatment, both Sanofi and Takeda have brought to market numerous therapeutic drugs to treat diabetes over the years and have built up

PH-COPD is a serious complication of COPD that can affect the health status of patients with this condition. Current standard of care for PH-COPD patients is primarily limited

FDA breakthrough therapy status helps in accelerating the development and review of drugs for serious or life-threatening conditions if preliminary clinical evidence indicates the therapy may show a

The Phase IIb trial, called AURA–LV (Aurinia Urine protein Reduction in Active Lupus with voclosporin) or AURA, is planned to be carried out in about 20 countries. The

The agreement includes exclusive commercialization in Mexico by Liomont of two biosimilars developed by Oncobiologics. As part of the deal, Liomont will provide Oncobiologics with upfront licensing and